{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:50:09Z","timestamp":1781859009769,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU58DP006808"],"award-info":[{"award-number":["NU58DP006808"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["NU58DP007147"],"award-info":[{"award-number":["NU58DP007147"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.japh.2024.102102","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T22:44:03Z","timestamp":1713653043000},"page":"102102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trends in varenicline use for tobacco cessation, and their implications"],"prefix":"10.1016","volume":"64","author":[{"given":"Zarrmein","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-7195","authenticated-orcid":false,"given":"Jeffrey R.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Dearden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0793-3351","authenticated-orcid":false,"given":"Michelle","family":"Strait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9538-8268","authenticated-orcid":false,"given":"Katie","family":"Treend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Glesmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8312-4137","authenticated-orcid":false,"given":"Beatriz H.","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2024.102102_bib3","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","article-title":"Quitting smoking among adults - United States, 2000-2015","volume":"65","author":"Babb","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.japh.2024.102102_bib4","series-title":"Smoking Cessation. A Report of the Surgeon General","year":"2020"},{"issue":"2","key":"10.1016\/j.japh.2024.102102_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amepre.2008.04.009","article-title":"Clinical practice Guideline treating tobacco U, dependence Update Panel L, Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public health service report","volume":"35","year":"2008","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.japh.2024.102102_bib6","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1164\/rccm.202005-1982ST","article-title":"Initiating Pharmacologic treatment in tobacco-Dependent adults. An Official American Thoracic Society clinical practice guideline","volume":"202","author":"Leone","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.japh.2024.102102_bib7","series-title":"UpToDate","article-title":"Pharmacotherapy for Smoking Cessation in Adults","author":"Rigotti","year":"2023"},{"key":"10.1016\/j.japh.2024.102102_bib8","series-title":"Abeloff\u2019s Clinical Oncology","first-page":"399","article-title":"Nicotine dependence: current treatments and future directions","author":"Engelmann","year":"2020"},{"issue":"6","key":"10.1016\/j.japh.2024.102102_bib9","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ije\/dyx109","article-title":"The effectiveness of varenicline versus nicotine replacement therapy on long-term smoking cessation in primary care: a prospective cohort study of electronic medical records","volume":"46","author":"Taylor","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"10037","key":"10.1016\/j.japh.2024.102102_bib10","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.japh.2024.102102_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54655","article-title":"Association of the Chantix recall with US prescribing of varenicline and other medications for nicotine dependence","volume":"6","author":"Lang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.japh.2024.102102_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.japh.2024.102102_bib14","series-title":"Fundamentals of Biostatistics","first-page":"606","author":"Rosner","year":"2000"},{"issue":"17","key":"10.1016\/j.japh.2024.102102_bib15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1915314","article-title":"Hospitalizations and deaths associated with EVALI","volume":"382","author":"Werner","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"e2","key":"10.1016\/j.japh.2024.102102_bib16","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1136\/tobaccocontrol-2021-056807","article-title":"The EVALI outbreak and tobacco sales in the USA, 2014-2020","volume":"32","author":"Liber","year":"2023","journal-title":"Tob Control"},{"issue":"2","key":"10.1016\/j.japh.2024.102102_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ntr\/ntac227","article-title":"The Impact of the COVID-19 pandemic on smoking, vaping, and smoking cessation services in the United Kingdom: a qualitative study","volume":"25","author":"Johnston","year":"2023","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.japh.2024.102102_bib18","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.5888\/pcd19.210430","article-title":"A\u00a0Rapid evaluation of the US federal tobacco 21 (T21) Law and Lessons from Statewide T21 policies: Findings from population-Level Surveys","volume":"19","author":"Agaku","year":"2022","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"10.1016\/j.japh.2024.102102_bib19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.japh.2023.01.010","article-title":"A\u00a0pragmatic review of varenicline prescribing practices","volume":"63","author":"Skoloda","year":"2023","journal-title":"J\u00a0Am Pharm Assoc (2003)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:29:47Z","timestamp":1778617787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1544319124001225"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102102","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in varenicline use for tobacco cessation, and their implications","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102102"}}